Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy, concepts, current trials and future directions

P Tolstoshev1

  • 1Research and Development, Genetic Therapy, Inc., Gaithersburg, Maryland 20878.

Annual Review of Pharmacology and Toxicology
|January 1, 1993
PubMed
Summary

Gene therapy shows early promise for genetic diseases like ADA deficiency and cancers using retroviral vectors. Further research is needed for effective in vivo gene delivery and broader clinical applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

Science (New York, N.Y.)·1995
Same author

Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1995
Same author

Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA.

Human gene therapy·1994
Same author

Retroviral-mediated gene therapy--safety considerations and preclinical studies.

Bone marrow transplantation·1992
Same author

Gene expression using retroviral vectors.

Current opinion in biotechnology·1990
Same author

Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor.

Proceedings of the National Academy of Sciences of the United States of America·1988

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Medical Genetics

Background:

  • Retroviral-mediated gene transfer clinical trials began in the USA in 1989.
  • Gene therapy is being explored for treating genetic diseases and cancers.
  • Gene marking is utilized in autologous bone marrow transplantation protocols.

Purpose of the Study:

  • To review the progress and applications of gene therapy since its inception.
  • To highlight the therapeutic potential and ongoing research in gene therapy.
  • To discuss the development of vector systems and delivery methods.

Main Methods:

  • Review of clinical trial data and proposed protocols.
  • Analysis of gene-marking applications in cancer therapy.
  • Evaluation of drug delivery potential using lymphokines and cytokines.

Main Results:

  • Encouraging clinical benefits observed in ADA deficiency treatment.
  • Gene marking extensively used in cancer and bone marrow transplantation.
  • Testing initiated for Familial Hypercholesterolemia and Hemophilia B.

Conclusions:

  • Gene therapy demonstrates early clinical success and rapid development.
  • Vector systems and delivery methods are advancing, including liposome-based trials.
  • Innovative research for in vivo vectors is crucial for realizing gene therapy's full potential.

Related Experiment Videos